The susceptibility to trisodium phosphonoformate of five strains of pigeon herpesvirus (Pigeon Herpesvirus 1, PHV) was compared by measuring the mean plaque size variations in the presence of different concentrations of the compound.
INTRODUCTION
Disodium phosphonoacetate and trisodium phosphonoformate are recently discovered antiherpetic compounds which are slightly cytotoxic and exhibit an important antiviral effect due to a specific inhibition of the herpesvirus-induced DNA-polymerase (Overby et al, 1974; Mao and Robishaw, 1975; Helgstrand etal, 1978) . A possible mechanism of inhibition is an interference with a pyrophosphate binding site on the polymerase (Oberg and Helgstrand and Oberg, 1978) .
Susceptibility to these two compounds has been reported for all the herpesviruses so far studied, for instance turkey herpesvirus {Turkey Herpesvirus 1, HVT), Marek's disease virus (Phasianid Herpesvirus 2, MDV) Reno et al, 1978) and pigeon herpesvirus (Pigeon Herpesvirus 1, PHV) (Schwers et al., 1980) . Some strains of several herpesviruses were found to be resistant (Jofre et al, 1977; Duff etal. 1978; Reno etal, 1978) .
For therapeutic purpose, the use of phosphonoacetate is limited because of its topical irritative potential (Kern etal., 1978) , its toxicity for laboratory animals and its accumulation in bones (Bopp et al, 1977) . Phosphonoformate does not irritate the skin or the mucous membranes, and has been successfully used for the treatment of experimental cutaneous and ocular herpes simplex type 1 (Human Herpesvirus 1, HSV1) infection Oberg et al, 1978) or genital infection of guinea pigs with herpes simplex type 2 (Human Herpesvirus 2, HSV2) (Alenius and Nordlinder, 1979) . Furthermore, phosphonoformate has only minor effects on normal cellular metabolism .
The present report deals with the comparison between the susceptibility of several strains of pigeon herpesvirus to phosphonoformate by measuring the effect of this compound on the mean size of plaques produced under agarose overlay. This investigation was performed with a view to a possible clinical application for the treatment of local lesions produced by PHV.
MATERIALS AND METHODS Viruses
Two strains of PHV (PHV/B/Cu 2 and PHV/B/Cu 3 ) were isolated in our laboratory at Brussels (Cureghem) from young pigeons , and a third one from psittacine birds (PHV/Psi/B/Cu) (Vindevogel etal, 1978; Vindevogel, etai, 1980) . A strain of PHV isolated in Czechoslovakia (PHV/Cz/V 236/69) (Krupitka et al., 1970) was kindly provided by Dr. Smid (Veterinary Research Institute, Hudcova), and another one isolated in Australia (PHV/A/B 50) (Boyle and Binnington, 1973) was obtained from Dr. Simmons (Animal Research Institute, Queensland).
Cell cultures
Chicken embryo fibroblasts (CEF) were cultured as previously described (Vindevogel etal, 1975) .
Production of plaques
Confluent cell monolayers, grown in Petri dishes (plastic Falcon; 30 mm diam.) were inoculated with 0.2 ml of 10-fold viral dilutions. After 1 hour of adsorption, the infected cells were covered with Minimum Essential Medium (MEM) containing 1% agarose (indubiose) and 2% foetal bovine serum. This overlay medium was supplemented with trisodium phosphonoformate at the following final concentrations: 10 and 100 /nM/ml. As controls, the same procedure was followed on uninfected cells and inoculated cells were incubated with maintenance medium devoid of phosphonoformate.
All the experiments were done on the same day, in the same CEF culture and with the same medium. The cells were fixed with formaldehyde after 4 days of incubation, then stained with May-Griinwald Giemsa (Vindevogel et al., 1975) . The experiments were twice repeated.
Measurement of mean plaque size
Cell cultures inoculated with the optimal viral dilution, causing a sufficient number of isolated plaques, were examined according to a method previously described (Jetteur etal, 1979; Pastoret etal, 1979; Schwersef al, 1980) . Briefly, plaques were printed with an offset camera to obtain a final magnification of x 20. For each virus at each concentration of phosphonoformate, the areas of 50 plaques taken at random were measured with an OH Kempton planimeter. Statistical tests Normality test. The normality of the plaque size distribution was studied by skewness and kurtosis tests.
Analysis of variance. The effect of the addition of trisodium phosphonoformate at increasing concentrations in the medium was studied by a one-way analysis of variance. Student's t-test was used to determine which concentrations of phosphonoformate were producing a significant reduction of the plaque size. Interaction test. To see if the susceptibility to phosphonoformate was the same for each strain, a two-way analysis of variance was performed and the hypothesis of absence of interaction was tested by the F-test.
RESULTS
The mean of the plaque size for PHV is given in Table 1 . 
Normality test
The sizes of the plaque population produced by PHV strains were not quite normally distributed in the presence of phosphonoformate. The square root of the plaque size always followed a normal distribution, thus allowing variance analysis.
Analysis of variance
Addition of phosphonoformate induced a marked reduction of the mean plaque size (P < 0.001) for each of the five strains studied. By use of the t-test, a significant reduction of the mean plaque size with each concentration of trisodium phosphonoformate (10, 100 /iM/ml) (P < 0.02) was found, except for PHV/B/Cu 3 and PHV/Psi/B/Cu strains. Indeed, the addition of more than 10 juM/ml phosphonoformate in the presence of PHV/B/Cu 3 did not induce a further reduction in the mean size; for PHV/Psi/B/Cu we did not observe a significant reduction of the plaque size after addition of 10 /nM/ml of phphonoformate, but we did so after the addition of 100 juM/ml (Text- fig. 1 ).
Comparison between the strains by their mean plaque size reduction in the presence of phosphonoformate
Significant differences were observed between the strains from the point of view of mean plaque size reduction in the presence of phosphonoformate (p < 0.001). All the strains studied differed from each other on the basis of the determination of their reduction rate in the presence of 10 or 100 /uM/ml of phosphonoformate (Text- fig. 1 ). The most susceptible strain was PHV/Cz/V 236/69, followed by PHV/B/Cu 2 , PHV/A/B 50 and PHV/B/Cu 3 ; PHV/B/Cu 3 was less susceptible than the other strains at high concentrations, whereas PHV/Psi/B/Cu was the least susceptible. A second experiment gave similar results. Text- fig. 1 . Comparison between the mean plaque size reduction of PHV strains with increasing concentrations of trisodium phosphonoformate.
DISCUSSION All the PHV strains studied were susceptible to trisodium phosphonoformate. In fact, the mean plaque size of the different PHV strains was reduced in the presence of phosphonoformate and, by comparing their reduction rate, it can be shown that each strain differs from any other according to its susceptibility to the compound. This agrees with the observations of Reno et al. (1978) who described variations between several strains of HVT in their susceptibility of phosphonoformate, some of them being resistant.
The strain isolated from psittacines was less susceptible than the other strains although it was a typical PHV strain . It remains to be studied whether these differences within the same viral species are as important as those between two different species (Schwers et al., 1980) . The finding that there are differences between several strains of PHV in the presence of phosphonoformate may be important from the point of view of a possible clinical application in the treatment of local lesions produced by PHV infection, notwithstanding the fact that none of the PHV strains studied was found to be naturally resistant to the compound. 
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